Evidence map›Paper›PMID 28631068›Full record

ReviewCurrent rheumatology reports2017

Autoinflammatory Diseases with Periodic Fevers.

Erdal Sag, Yelda Bilginer, Seza Ozen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current rheumatology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Clinical phenotype,Frontiers in immunology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Autoinflammatory manifestations in adult patients.Clinical and experimental immunology · 2022
    Article
  12. Article
  13. Review
  14. [Autoinflammation-A clinical and genetic challenge].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2022
    Article
  15. Pediatric uveitis: Role of the pediatrician.Frontiers in pediatrics · 2022
    Review
  16. [Autoinflammation-A clinical and genetic challenge].Zeitschrift fur Rheumatologie · 2021
    Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Erdal SagInstitute of Child Health, Pediatric Autoinflammatory Disease Programme, Hacettepe University, Ankara, Turkey.
Yelda BilginerDepartment of Pediatric Rheumatology, Hacettepe University Ihsan Dogramaci Children's Hospital, 06230, Sihhiye, Ankara, Turkey.
Seza OzenDepartment of Pediatric Rheumatology, Hacettepe University Ihsan Dogramaci Children's Hospital, 06230, Sihhiye, Ankara, Turkey. sezaozen@hacettepe.edu.tr.
Hacettepe University Hospital · TRHacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewOne purpose of this review was to raise awareness for the new autoinflammatory syndromes. These diseases are increasingly recognized and are in the differential diagnosis of many disease states. We also aimed to review the latest recommendations for the diagnosis, management, and treatment of these patients. RECENT

findingsFamilial Mediterranean fever (FMF), cryopyrin-associated periodic syndrome (CAPS), tumor necrosis factor receptor-associated periodic fever syndrome (TRAPS), and hyperimmunoglobulinemia D and periodic fever syndrome/mevalonate kinase deficiency (HIDS/MVKD) are the more common autoinflammatory diseases that are characterized by periodic fevers and attacks of inflammation. Recently much collaborative work has been done to understand the characteristics of these patients and to develop recommendations to guide the physicians in the care of these patients. These recent recommendations will be summarized for all four diseases. FMF is the most common periodic fever disease. We need to further understand the pathogenesis and the role of single mutations in the disease. Recently, the management and treatment of the disease have been nicely reviewed. CAPS is another interesting disease associated with severe complications. Anti-interleukin-1 (anti-IL-1) treatment provides cure for these patients. TRAPS is characterized by the longest delay in diagnosis; thus, both pediatricians and internists should be aware of the characteristic features and the follow-up of these patients. HIDS/MVKD is another autoinflammatory diseases characterized with fever attacks. The spectrum of disease manifestation is rather large in this disease, and we need further research on biomarkers for the optimal management of these patients.

Indexed as

Cryopyrin-Associated Periodic SyndromesDiagnosis, DifferentialFamilial Mediterranean FeverFeverHereditary Autoinflammatory DiseasesHumansMevalonate Kinase DeficiencyAutoinflammatory syndromesPeriodic fever diseases

Identifiers

PMID28631068
OpenAlexW2705475387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.